Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$9.81 CAD
Change Today -0.195 / -1.95%
Volume 408.0
As of 3:59 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas Glen Janzen

Independent Director, Member of Audit Committee and Member of Compensation Committee, Neovasc Inc.
AgeTotal Calculated CompensationThis person is connected to 68 board members in 5 different organizations across 10 different industries.

See Board Relationships


Mr. Douglas G. Janzen, also known as Doug, serves as the Chairman, Chief Executive Officer and President of Aequus Pharmaceuticals Inc. Mr. Janzen served as the President and Chief Executive Officer of Cardiome Pharma Corp., from March 8, 2006 to July 2012 and from August 2009 to July 2012 respectively. He is the Founder and President of NorthView Ventures. Mr. Janzen has an extensive experience in corporate banking and financing for Canadian Biotechnology companies. ...

Read Full Background

Corporate Headquarters*

13562 Maycrest Way
Richmond, British Columbia V6V 2J7


Phone: 604-270-4344
Fax: 604-270-4384

Board Members Memberships*

Former Chief Executive Officer, President and Director
Independent Director, Member of Audit Committee and Member of Compensation Committee
Former Director
Chairman, Chief Executive Officer and President


Master's Degree
University Of British Columbia
Unknown/Other Education
University of Saskatchewan

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVC:CN C$9.81 CAD -0.195


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOVASC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at